$78.64
Value $131B
AltriavsPetMed Express
MO and PETS stock compared: price, dividend, valuation and results, from SEC filings.
+0.92%
$0.94
Value $20M
Altria (MO) has a market value of $131B and PetMed Express (PETS) $20M. Over the last year, with dividends, MO moved +44.7% and PETS -67.6%. Dividend yield: MO 5.46%, PETS none.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MO$131B
PETS$20M
MO is 6,545 times PETS
Revenue, 12 months
MO$23.5B
PETS$160M
MO is 147 times PETS
Net income, 12 months
MO$8.1B
PETS-$27M
Operating margin
MO47.0%
PETS-18.0%
65.0 points apart
ROIC
MO38.4%
PETS-78.7%
117.1 points apart
P/E
MO16.2
PETS–
Dividend yield
MO5.5%
PETS0.0%
5.5 points apart
5-year return
MO+157.7%
PETS-96.5%
254.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MO+157.7%
PETS-96.5%
| Period | MOWith dividends | PETSWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +44.7%Price +35.5% | -67.6%Price -67.6% |
| 3 years since November 13, 2023 | +146.0%+35.0% a yearPrice +96.6% | -87.4%-49.8% a yearPrice -87.4% |
| 5 years since November 12, 2021 | +157.7%+20.8% a yearPrice +75.1% | -96.5%-48.7% a yearPrice -96.8% |
| 10 years since November 15, 2016 | +153.8%+9.8% a yearPrice +27.2% | -94.2%-24.8% a yearPrice -95.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
MOAltriaPETSPetMed Express
Valuation
MOPETS| Price | $78.64 | $0.94 |
|---|---|---|
| Market value | $131B | $20M |
| Enterprise value (EV) | $153B | $8.7M |
| P/E | 16.2 | – |
| P/E, 5-year median | 14.0 | – |
| P/B | – | 1.2 |
| EV/EBIT | 13.8 | – |
| Free cash flow yield | 6.9% | – |
Results and growth
MOPETS| Revenue, 12 months | $23.5B | $160M |
|---|---|---|
| Net income, 12 months | $8.1B | -$27M |
| Free cash flow, 12 months | $9.1B | -$25M |
| Earnings per share, 12 months | $4.85 | -$1.28 |
| Revenue growth, year on year | -3.1% | -21.1% |
| Revenue growth a year, past | -2.3%over 5 years | -10.0%over 5 years |
| EPS growth a year, past | +11.4%over 5 years | – |
Margins and returns on capital
MOPETS| Gross margin | 63.3% | 27.8% |
|---|---|---|
| Operating margin | 47.0% | -18.0% |
| Net margin | 34.5% | -17.0% |
| ROIC | 38.4% | -78.7% |
| ROE | – | -94.0% |
Balance sheet
MOPETS| Cash | $2.7B | $11M |
|---|---|---|
| Total debt | $24.1B | $291.0K |
| Net debt / EBITDA | 1.9 | – |
| Interest cover | 9.4× | – |
Dividends and buybacks
MOPETS| Dividend yield | 5.5% | – |
|---|---|---|
| Dividend per share, 12 months | $4.29 | – |
| Dividend growth a year, past | +4.1%over 5 years | – |
| Buyback yield | 0.8% | – |
| Shareholder yield | 6.2% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Altria or PetMed Express?
By market value, Altria ($131B) is about 6,545.1 times PetMed Express ($20M), at today's prices.
How did MO and PETS stock do over the last 10 years?
Since November 15, 2016, MO's price moved +27.2% and PETS's -95.7%. With dividends: MO +153.8% (+9.8% a year), PETS -94.2% (-24.8% a year). Past returns do not predict future ones.
Which pays the higher dividend, MO or PETS?
The dividend yield at today's price is 5.46% for Altria and none for PetMed Express. Over the last twelve months they paid $4.29 and – per share.
Which has the higher profit margins, Altria or PetMed Express?
Over the last twelve months, the net margin was 34.5% for Altria and -17.0% for PetMed Express, and the operating margin 47.0% and -18.0%. Revenue was $23.5B and $160M.
Which is the better investment, Altria or PetMed Express?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.